Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
7.3
196.18%
60%
—
7x
Every year
—
5 Years
Score7.3
Net Growth196.18%
Net Trend60%
Net Income Consistency—
Rev Growth7x
Rev TrendEvery year
Revenue Consistency—
Oscar Health Inc fundamental performance
Between 2021 and 2025, revenue grew from $ 1.92B to $ 11.70B and net income went from -$ 572M to -$ 443M. Revenue increased in 100% of the years measured; net income in 60%.
Oscar Health Inc currently holds a 5-year HDB Score of 7.3 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 29.61 | — |
1 Year2025-08-12 | $ 14.98 | 97.66% |
5 Years2021-08-12 | $ 14.66 | 101.98% |
All Time2021-03-03 | $ 34.80 | -14.91% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2021-03-03 |
|---|---|---|---|---|
| Price | $ 29.61 | $ 14.98 | $ 14.66 | $ 34.80 |
| Return | — | 97.66% | 101.98% | -14.91% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 15.31B | $ 550M | $ 8.55B |
| 2025 | $ 11.70B | -$ 443M | $ 3.99B |
| 2024 | $ 9.17B | $ 25M | $ 2.15B |
| 2023 | $ 5.86B | -$ 270M | $ 2.56B |
| 2022 | $ 4.12B | -$ 606M | $ 2.95B |
| IPO2021 | $ 1.92B | -$ 572M | $ 1.69B |
Explore beyond OSCR
You're looking at Oscar Health Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
Explore other companies
- Hyperfine IncHYPR· revenue grew in 100% of years
- Amneal Pharmaceuticals, Inc. Class A Common StockAMRX· revenue grew in 100% of years
- Protagonist Therapeutics IncPTGX· revenue grew in 60% of years
- Tactile Systems Technology IncTCMD· revenue grew in 100% of years
- Incyte CorporationINCY· revenue grew in 100% of years
